Abrdn Life Sciences Investors
(NYSE) HQL
Abrdn Life Sciences Investors Financials at a Glance
Market Cap
$514.50M
Revenue (TTM)
$33.81M
Net Income (TTM)
$170.89M
EPS (TTM)
$2.89
P/E Ratio
5.85
Dividend
$2.04
Beta (Volatility)
0.75 (Low)
Dividend
$2.04
Beta (Volatility)
0.75 (Low)
Price
$16.91
Volume
126,999.501
Open
$17.25
Price
$16.91
Volume
126,999.501
Open
$17.25
Previous Close
$16.92
Daily Range
$16.59 - $17.29
52-Week Range
$12.34 - $18.46
Estimated Earnings Date
Jun 24, 2025
Dividend
$2.04
Beta (Volatility)
0.75 (Low)
Price
$16.91
Volume
126,999.501
Open
$17.25
Previous Close
$16.92
Daily Range
$16.59 - $17.29
52-Week Range
$12.34 - $18.46
Estimated Earnings Date
Jun 24, 2025
HQL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abrdn Life Sciences Investors
Industry
Capital Markets
Sector
FinancialsWebsite
www.teklacap.com/hql.htmlHeadquarters
Philadelphia, MA 02110, US
HQL Financials
Key Financial Metrics (TTM)
Gross Margin
31%
Operating Margin
3%
Net Income Margin
3%
Return on Equity
18%
Return on Capital
17%
Return on Assets
17%
Earnings Yield
17.09%
Dividend Yield
12.06%
Payout Ratio
36.96%
Stock Overview
Market Cap
$514.50M
Shares Outstanding
30.41M
Volume
127.00K
Avg. Volume
104.97K
Financials (TTM)
Gross Profit
$86.39M
Operating Income
$85.59M
EBITDA
$85.59M
Operating Cash Flow
-$2.32M
Capital Expenditure
-$5.00
Free Cash Flow
-$2.32M
Cash & ST Invst.
$75.54K
Total Debt
$0.00
Abrdn Life Sciences Investors Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.63M
-60.6%
Gross Profit
$9.19M
-65.9%
Gross Margin
78.99%
N/A
Market Cap
$514.50M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$132.83M
+1260.0%
EBITDA
$132.83M
+1260.3%
Quarterly Fundamentals
Net Cash
$75.54K
-99.5%
Accounts Receivable
$1.14M
-77.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
16.61%
N/A
Return on Invested Capital
16.63%
N/A
Free Cash Flow
-$1.28M
N/A
Operating Cash Flow
-$1.28M
N/A